As of 2025-11-18, the Relative Valuation of XSpray Pharma AB (publ) (XSPRAY.ST) is (128.46) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 26.40 SEK, the upside of XSpray Pharma AB (publ) based on Relative Valuation is -586.6%.
The range of the Relative Valuation is (100.38) - (134.81) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 32.7x | 26.5x |
| Forward P/E multiples | 19.2x - 26.0x | 23.0x |
| Fair Price | (100.38) - (134.81) | (128.46) |
| Upside | -480.2% - -610.6% | -586.6% |
| Date | P/E |
| 2025-11-14 | -5.09 |
| 2025-11-13 | -5.04 |
| 2025-11-12 | -4.99 |
| 2025-11-11 | -4.93 |
| 2025-11-10 | -4.98 |
| 2025-11-07 | -4.93 |
| 2025-11-06 | -4.87 |
| 2025-11-05 | -4.76 |
| 2025-11-04 | -4.80 |
| 2025-11-03 | -4.88 |
| 2025-10-31 | -4.96 |
| 2025-10-30 | -5.13 |
| 2025-10-29 | -5.05 |
| 2025-10-28 | -5.01 |
| 2025-10-27 | -4.97 |
| 2025-10-24 | -5.03 |
| 2025-10-23 | -4.97 |
| 2025-10-22 | -4.92 |
| 2025-10-21 | -5.05 |
| 2025-10-20 | -4.94 |
| 2025-10-17 | -5.01 |
| 2025-10-16 | -5.27 |
| 2025-10-15 | -5.30 |
| 2025-10-14 | -5.18 |
| 2025-10-13 | -4.84 |
| 2025-10-10 | -4.95 |
| 2025-10-09 | -5.16 |
| 2025-10-08 | -5.22 |
| 2025-10-07 | -12.23 |
| 2025-10-06 | -11.19 |
| 2025-10-03 | -11.49 |
| 2025-10-02 | -11.59 |
| 2025-10-01 | -12.11 |
| 2025-09-30 | -11.57 |
| 2025-09-29 | -11.59 |
| 2025-09-26 | -10.99 |
| 2025-09-25 | -11.49 |
| 2025-09-24 | -10.26 |
| 2025-09-23 | -10.38 |
| 2025-09-22 | -10.03 |
| 2025-09-19 | -10.14 |
| 2025-09-18 | -10.11 |
| 2025-09-17 | -10.13 |
| 2025-09-16 | -10.72 |
| 2025-09-15 | -9.78 |
| 2025-09-12 | -9.18 |
| 2025-09-11 | -9.42 |
| 2025-09-10 | -8.74 |
| 2025-09-09 | -9.01 |
| 2025-09-08 | -9.36 |